| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Clinical Pharmacist Patient-Centered Approach to Achieving Lipid Goals by Adding Controlled-Release Niacin to Moderate or High-Intensity Statin
|
Schwellenbach, Lisa J.
|
|
2015
|
9 |
3 |
p. 475-
1 p.
|
artikel
|
| 2 |
A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine
|
Lamprecht, Donald G.
|
|
2015
|
9 |
3 |
p. 436-437
2 p.
|
artikel
|
| 3 |
A Comparative Study of Four Independent Methods to Measure LDL Particle Concentration
|
Hopkins, Paul N.
|
|
2015
|
9 |
3 |
p. 412-413
2 p.
|
artikel
|
| 4 |
A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines and the 2004 ATP III Cholesterol Guidelines among Ryan Nena Community Health Center Patients*
|
Keppel, Sunny-Skye
|
|
2015
|
9 |
3 |
p. 440-
1 p.
|
artikel
|
| 5 |
A Comparison of the Pharmacological and Mechanistic Properties of Therapeutic Long-Chain Omega-3 Fatty Acid Formulations
|
Harper, Charles R.
|
|
2015
|
9 |
3 |
p. 465-466
2 p.
|
artikel
|
| 6 |
Adenosine triphosphate citrate lyase: Emerging target in the treatment of dyslipidemia
|
Lemus, Hernán N.
|
|
2015
|
9 |
3 |
p. 384-389
6 p.
|
artikel
|
| 7 |
Adolescent and adult African Americans have similar metabolic dyslipidemia
|
Gidding, Samuel S.
|
|
2015
|
9 |
3 |
p. 368-376
9 p.
|
artikel
|
| 8 |
Alirocumab Treatment Effect on Non-HDL-C: Pooled Analyses of 10 Phase 3 Trials in the ODYSSEY Program
|
Bays, Harold E.
|
|
2015
|
9 |
3 |
p. 471-472
2 p.
|
artikel
|
| 9 |
Analysis of Dyslipidemia in Children with Type 2 Diabetes Mellitus*
|
Pelham, James H.
|
|
2015
|
9 |
3 |
p. 418-419
2 p.
|
artikel
|
| 10 |
An Electronic Phenotyping Algorithm to Rapidly Ascertain Familial Hypercholesterolemia in Healthcare Systems*
|
Safarova, Maya S.
|
|
2015
|
9 |
3 |
p. 426-427
2 p.
|
artikel
|
| 11 |
Application of the New Cholesterol Treatment Guidelines in Current Clinical Practice*
|
Jordan, Jonathan N.
|
|
2015
|
9 |
3 |
p. 439-440
2 p.
|
artikel
|
| 12 |
A 3-Year-Old with Severe Hypercholesterolemia*
|
Patel, Amol M.
|
|
2015
|
9 |
3 |
p. 444-
1 p.
|
artikel
|
| 13 |
Baseline Lipid Profiles and Statin Use among Patients with Atherosclerotic Cardiovascular Disease
|
Toth, Peter P.
|
|
2015
|
9 |
3 |
p. 441-
1 p.
|
artikel
|
| 14 |
Biomarkers of Cholesterol Homeostasis in a Clinical Laboratory Database Sample Comprising 667,718 Patients
|
Dayspring, Thomas D.
|
|
2015
|
9 |
3 |
p. 416-
1 p.
|
artikel
|
| 15 |
Body Mass Index and Apolipoproteins C-III, B, and A-I in Young Adult Cherokee
|
Blackett, Piers R.
|
|
2015
|
9 |
3 |
p. 426-
1 p.
|
artikel
|
| 16 |
Can CME Impact Knowledge and Competence Related to PCSK9 Inhibitors?
|
Larkin, Amy T.
|
|
2015
|
9 |
3 |
p. 459-460
2 p.
|
artikel
|
| 17 |
Can Low-Radiation Coronary Computed Tomography Angiography Improve Upon Clinical Risk Assessment in Patients with Familial Hypercholesterolemia?*
|
Sicilia, Anna T.
|
|
2015
|
9 |
3 |
p. 434-435
2 p.
|
artikel
|
| 18 |
Cardiovascular Screening in Youth*†
|
Mou, Margaret
|
|
2015
|
9 |
3 |
p. 443-444
2 p.
|
artikel
|
| 19 |
Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux
|
Anthanont, Pimjai
|
|
2015
|
9 |
3 |
p. 390-395
6 p.
|
artikel
|
| 20 |
Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations
|
Panza, Gregory A.
|
|
2015
|
9 |
3 |
p. 351-356
6 p.
|
artikel
|
| 21 |
Cholesterol in Remnant-Lipoproteins as Measured by Different Methods
|
Toth, Peter P.
|
|
2015
|
9 |
3 |
p. 414-415
2 p.
|
artikel
|
| 22 |
Citrus Bergamot Improves Atherogenic Lipoprotein Particle Characteristics in Patients With Non-alcoholic Fatty Liver Disease and Metabolic Syndrome†
|
Ehrlich, James E.
|
|
2015
|
9 |
3 |
p. 473-474
2 p.
|
artikel
|
| 23 |
Clinical Characteristics and Unmet Need Among Real-World Atherosclerotic Cardiovascular Disease (ASCVD) Patients Stratified by Statin Use
|
Huang, Qing
|
|
2015
|
9 |
3 |
p. 437-438
2 p.
|
artikel
|
| 24 |
Clinical Practice Gaps Related to Lipid Management in Patients with Type 2 Diabetes
|
Larkin, Amy T.
|
|
2015
|
9 |
3 |
p. 444-445
2 p.
|
artikel
|
| 25 |
Comparison of Lipid and Anti-inflammatory Levels Between Rosuvastatin Or Atorvastatin Daily vs. Thrice Weekly “Doubled-daily” Dosing*
|
Venero, Carmelo V.
|
|
2015
|
9 |
3 |
p. 456-457
2 p.
|
artikel
|
| 26 |
Coronary Artery Disease Risk in a Saudi Arabia Population, Lipoprotein Subclass Distribution, and Gender Differences
|
Superko, H. Robert
|
|
2015
|
9 |
3 |
p. 448-449
2 p.
|
artikel
|
| 27 |
Determination of Serum Triacylglyceride Reduction Using Patented Microbial Lipase
|
Penet, Christopher S.
|
|
2015
|
9 |
3 |
p. 433-434
2 p.
|
artikel
|
| 28 |
Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*†
|
Ahmad, Zahid
|
|
2015
|
9 |
3 |
p. 451-452
2 p.
|
artikel
|
| 29 |
Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia
|
Skulas-Ray, Ann C.
|
|
2015
|
9 |
3 |
p. 360-367
8 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
2015
|
9 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 31 |
Effectiveness of Comprehensive Laboratory Testing in Identifying Residual Cardiometabolic Risk Among Cardiac Rehabilitation Patients
|
Alagona, Peter
|
|
2015
|
9 |
3 |
p. 415-416
2 p.
|
artikel
|
| 32 |
Effect of Duration of Statin Treatment on all Cause Mortality: A Meta-Analysis of Randomized Control Trials*
|
Krishnamoorthy, Parasuram
|
|
2015
|
9 |
3 |
p. 442-
1 p.
|
artikel
|
| 33 |
Effect of HDL on Platelet Mitochondria, Apoptosis and Aggregation*
|
Song, Wen-Liang
|
|
2015
|
9 |
3 |
p. 430-431
2 p.
|
artikel
|
| 34 |
Effect of Statins (Atorvastatin, Pitavastatin, Pravastatin, Rosuvastatin and Simvastatin) and Coenzyme Q10 (CoQ10) on Adenosine Triphosphate (ATP) Levels
|
Ito, Matthew K.
|
|
2015
|
9 |
3 |
p. 419-420
2 p.
|
artikel
|
| 35 |
Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study)
|
Ballantyne, Christie M.
|
|
2015
|
9 |
3 |
p. 377-383
7 p.
|
artikel
|
| 36 |
Efficacy and Safety of Sebelipase Alfa in Children and Adults with Lysosomal Acid Lipase Deficiency: Results of a Phase 3 Trial†
|
Rojas-Caro, Sandra
|
|
2015
|
9 |
3 |
p. 429-430
2 p.
|
artikel
|
| 37 |
Eicosapentaenoic Acid (EPA), But Not Other TG-Lowering Agents, Reduces Cholesterol Domain Levels in Atherosclerotic-Like Model Membranes
|
Mason, R. Preston
|
|
2015
|
9 |
3 |
p. 466-
1 p.
|
artikel
|
| 38 |
Estimation of 10 Year Framingham Cardiovascular (CV) Risk of Adults with Lysosomal Acid Lipase (LAL) Deficiency†
|
Shah, Digisha S.
|
|
2015
|
9 |
3 |
p. 455-456
2 p.
|
artikel
|
| 39 |
Evaluation of Adverse Events Associated with Niacin in Patients Treated in an Outpatient Lipid Clinic
|
Albro, Elise A.
|
|
2015
|
9 |
3 |
p. 476-
1 p.
|
artikel
|
| 40 |
Evaluation of Effects of the Weak CYP3A4 Inhibitors Atorvastatin and Ethinyl Estradiol/Norgestimate on Lomitapide Pharmacokinetics in Healthy Subjects
|
Patel, Gina
|
|
2015
|
9 |
3 |
p. 447-448
2 p.
|
artikel
|
| 41 |
Evaluation of Healthcare Care Utilization and Costs Related to Acute Pancreatitis for Patients with Very Severe Hypertriglyceridemia
|
Rashid, Nazia
|
|
2015
|
9 |
3 |
p. 431-432
2 p.
|
artikel
|
| 42 |
Evaluation of Patients with Very Severe Hypertriglyceridemia in an Integrated Managed Care Healthcare System
|
Rashid, Nazia
|
|
2015
|
9 |
3 |
p. 432-433
2 p.
|
artikel
|
| 43 |
Ezetimibe Does Not Increase Fasting Glucose Levels More than Statins Alone in Non-diabetic, Hypercholesterolemic Patients
|
Toth, Peter P.
|
|
2015
|
9 |
3 |
p. 418-
1 p.
|
artikel
|
| 44 |
Factors Associated with Acute Pancreatitis among Patients with Very Severe Hypertriglyceridemia in an Integrated Managed Care Healthcare System
|
Rashid, Nazia
|
|
2015
|
9 |
3 |
p. 433-
1 p.
|
artikel
|
| 45 |
Familial Hypercholesterolemia(FH) Community Initiative Using Electronic Health Records(EHR)
|
Andersen, Rolf L.
|
|
2015
|
9 |
3 |
p. 451-
1 p.
|
artikel
|
| 46 |
Familial Hypercholesterolemia Prevalence of 1.5% in a Clinical Database of 542,214 Patients: Refined Risk Stratification Using ApoB:LDL-C Ratio
|
Varvel, Stephen A.
|
|
2015
|
9 |
3 |
p. 414-
1 p.
|
artikel
|
| 47 |
Fish Oil Omega-3 Blood Level Measurement Affects Patient Management
|
Superko, H. Robert
|
|
2015
|
9 |
3 |
p. 464-465
2 p.
|
artikel
|
| 48 |
From the Editor: Clinical lipidology is growing in its scientific strength and clinical relevance
|
Brown, W. Virgil
|
|
2015
|
9 |
3 |
p. 271-272
2 p.
|
artikel
|
| 49 |
Genetic Diagnosis of Familial Hypercholesterolemia in a Community Lipid Clinic
|
Trippi, James A.
|
|
2015
|
9 |
3 |
p. 427-429
3 p.
|
artikel
|
| 50 |
Giant xanthomas associated with severe mixed dyslipidemia and arteriosclerotic vascular disease: A case report
|
Charniot, Jean-Christophe
|
|
2015
|
9 |
3 |
p. 406-410
5 p.
|
artikel
|
| 51 |
Hemoglobin and Lipid Assessment of Children in Iquitos, Peru*
|
Ward, Samantha M.
|
|
2015
|
9 |
3 |
p. 456-
1 p.
|
artikel
|
| 52 |
Higher Prevalence of Atherogenic Lipoproteins in Overweight/Obese T2DM Adolescents Relative to T1DM Counterparts
|
Ashraf, Ambika P.
|
|
2015
|
9 |
3 |
p. 413-414
2 p.
|
artikel
|
| 53 |
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects on Remnant-like Particle Cholesterol From the MARINE and ANCHOR Studies†
|
Ballantyne, Christie M.
|
|
2015
|
9 |
3 |
p. 463-464
2 p.
|
artikel
|
| 54 |
Identification and Characterization of an ACC/AHA High-Risk Population: Patients with Low Density Lipoprotein Cholesterol ≥190 mg/dl*
|
Kelly, Erik
|
|
2015
|
9 |
3 |
p. 452-
1 p.
|
artikel
|
| 55 |
Identification and Characterization of Patients with Untreated or Undertreated Familial Hypercholesterolemia: A Single Center Retrospective Study*
|
Kelly, Erik
|
|
2015
|
9 |
3 |
p. 448-
1 p.
|
artikel
|
| 56 |
Incidence of Statin Intolerance in a Referral Lipid Clinic: Patient Characteristics and Response to Rechallenge*
|
Cheeley, Mary K.
|
|
2015
|
9 |
3 |
p. 461-462
2 p.
|
artikel
|
| 57 |
Interaction of Cholesterol Crystals with Pseudomonas Aeruginosa in Atherosclerosis*
|
Raju, Manjunath
|
|
2015
|
9 |
3 |
p. 467-468
2 p.
|
artikel
|
| 58 |
Is HPS2-THRIVE the death knell for niacin?
|
Toth, Peter P.
|
|
2015
|
9 |
3 |
p. 343-350
8 p.
|
artikel
|
| 59 |
Is 0.5 the Optimal Waist-to-Height Ratio for Predicting Cardio-Metabolic Risk in Children?
|
Shan, Devan K.
|
|
2015
|
9 |
3 |
p. 478-
1 p.
|
artikel
|
| 60 |
JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function
|
Brown, W. Virgil
|
|
2015
|
9 |
3 |
p. 274-280
7 p.
|
artikel
|
| 61 |
Lipid and Anthropometric Analysis of an Adolescent Population in Iquitos, Peru*
|
Colelli, Teresa M.
|
|
2015
|
9 |
3 |
p. 422-423
2 p.
|
artikel
|
| 62 |
Lipoprotein(a) Testing: Clinical Practice Patterns in an Urban Academic Center*
|
Man, Lillian C.
|
|
2015
|
9 |
3 |
p. 411-412
2 p.
|
artikel
|
| 63 |
Long-Term Efficacy of Non-Daily Statin Dosing in Previously Intolerant Patients: The Atlanta VA Medical Center Experience*
|
Fayfman, Maya
|
|
2015
|
9 |
3 |
p. 460-461
2 p.
|
artikel
|
| 64 |
Long-Term Follow Up of Bi-Weekly Lipoprotein Apheresis in A patient with Elevated Lipoprotein-(a) Shows Regression in Carotid Intima-Media Thickness
|
Anabtawi, Abeer
|
|
2015
|
9 |
3 |
p. 453-
1 p.
|
artikel
|
| 65 |
LOWER: A Registry Evaluating Long-Term Lomitapide Use in Patients with Homozygous Familial Hypercholesterolemia†
|
Underberg, James A.
|
|
2015
|
9 |
3 |
p. 445-
1 p.
|
artikel
|
| 66 |
Managing the Lipid Triad: Improving Physicians’ Understanding of the Role of Omega-3 Fatty Acids with CME
|
Larkin, Amy T.
|
|
2015
|
9 |
3 |
p. 466-467
2 p.
|
artikel
|
| 67 |
Myocardial infarction in a 36-year-old man with combined ABCA1 and APOA-1 deficiency
|
van Capelleveen, Julian C.
|
|
2015
|
9 |
3 |
p. 396-399
4 p.
|
artikel
|
| 68 |
News from the NLA
|
|
|
2015
|
9 |
3 |
p. 273-
1 p.
|
artikel
|
| 69 |
Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†
|
Sharma, Saurabh
|
|
2015
|
9 |
3 |
p. 476-478
3 p.
|
artikel
|
| 70 |
Omega-3 Fatty Acid Differences in a Saudi Arabia Population Compared to a US Population and Cardiovascular Risk†
|
Superko, H. Robert
|
|
2015
|
9 |
3 |
p. 467-
1 p.
|
artikel
|
| 71 |
Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition Examination Surveys
|
Moon, Joon Ho
|
|
2015
|
9 |
3 |
p. 334-342
9 p.
|
artikel
|
| 72 |
Overcoming Lipid Management Obstacles in a University-Based Cardiology Clinic
|
Kolakalapudi, Pavani
|
|
2015
|
9 |
3 |
p. 468-
1 p.
|
artikel
|
| 73 |
Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis
|
Tatachar, Amulya
|
|
2015
|
9 |
3 |
p. 326-333
8 p.
|
artikel
|
| 74 |
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†
|
Roth, Eli M.
|
|
2015
|
9 |
3 |
p. 420-421
2 p.
|
artikel
|
| 75 |
PCSK9 InsLEU Genetic Variant is Associated with Pre-Diabetes and Diabetes*
|
Saavedra, Yascara Luna
|
|
2015
|
9 |
3 |
p. 419-
1 p.
|
artikel
|
| 76 |
Pharmacokinetic and Triglyceride-lowering Pharmacodynamic Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) Across Clinical Studies†
|
Stirtan, William G.
|
|
2015
|
9 |
3 |
p. 464-
1 p.
|
artikel
|
| 77 |
Phase 1 Study of CAT-2054, an Oral Novel Modulator of SREBP
|
Donovan, Joanne M.
|
|
2015
|
9 |
3 |
p. 474-475
2 p.
|
artikel
|
| 78 |
Pitavastatin 4 mg Superior to Pravastatin 40 mg on LDL-C Reduction in HIV-Positive Patients with Dyslipidemia with and without Ritonavir-based Therapy†
|
Sponseller, Craig A.
|
|
2015
|
9 |
3 |
p. 452-453
2 p.
|
artikel
|
| 79 |
Plasma CTRP-3 concentrations in Chinese patients with obesity and type II diabetes negatively correlate with insulin resistance
|
Qu, Hua
|
|
2015
|
9 |
3 |
p. 289-294
6 p.
|
artikel
|
| 80 |
Practical Application of Updated Lipid Management Guidelines: Evaluating the Impact of CME
|
Larkin, Amy T.
|
|
2015
|
9 |
3 |
p. 435-436
2 p.
|
artikel
|
| 81 |
Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, Reduces Fasting Triglyceride Levels in Familial Chylomicronemia
|
Gaudet, Daniel
|
|
2015
|
9 |
3 |
p. 449-450
2 p.
|
artikel
|
| 82 |
Pradigastat Did Not Increase Fecal Bile Acids in Patients with Familial Chylomicronemia Syndrome After 52 Weeks
|
Zhou, Yinong
|
|
2015
|
9 |
3 |
p. 454-455
2 p.
|
artikel
|
| 83 |
Prediction of Cardiovascular Disease Events by Lipoprotein(a) According to LDL-C in Older High Risk Adults
|
Wong, Nathan D.
|
|
2015
|
9 |
3 |
p. 421-422
2 p.
|
artikel
|
| 84 |
Prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) and Diabetes Populations in the United States
|
Gorcyca, Katherine
|
|
2015
|
9 |
3 |
p. 424-
1 p.
|
artikel
|
| 85 |
Racial and Ethnic Disparity in Cardiovascular Risk Factor Control in Patients Presenting for Elective Catheterization*
|
Rudy, Hayeem
|
|
2015
|
9 |
3 |
p. 468-470
3 p.
|
artikel
|
| 86 |
Real-World Costs for First and Recurrent Events of Myocardial Infarction and Stroke in the Elderly Medicare Population
|
Becker, David
|
|
2015
|
9 |
3 |
p. 454-
1 p.
|
artikel
|
| 87 |
RETRACTED: Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia
|
McCrindle, Brian W.
|
|
2015
|
9 |
3 |
p. 447-
1 p.
|
artikel
|
| 88 |
Retrospective Analysis of Metabolic Control in Type 2 Diabetes with American Diabetes Association Recommendations compared with Carbohydrate Restriction
|
Hallberg, Sarah
|
|
2015
|
9 |
3 |
p. 420-
1 p.
|
artikel
|
| 89 |
Rise in Serum Lipids After Dietary Incorporation of “Bulletproof Coffee”
|
Toklu, Bora
|
|
2015
|
9 |
3 |
p. 462-
1 p.
|
artikel
|
| 90 |
Risk Factor Predominance in Atherosclerotic Cardiovascular Disease Differs by Race: An Observational Study*
|
Jarrett, Harish
|
|
2015
|
9 |
3 |
p. 423-
1 p.
|
artikel
|
| 91 |
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials
|
McKenney, James
|
|
2015
|
9 |
3 |
p. 313-325
13 p.
|
artikel
|
| 92 |
Shifts in Dyslipidemia Clinical Guidelines: Do they Affect Disease Management and Prescribing Patterns?*
|
Murphy, Courtney
|
|
2015
|
9 |
3 |
p. 441-442
2 p.
|
artikel
|
| 93 |
Short Total Sleep Time and Elevated Central Apnea Index are Significant Predictors of Coronary Artery Disease*
|
Constantin, Tina
|
|
2015
|
9 |
3 |
p. 424-426
3 p.
|
artikel
|
| 94 |
Statin Associated Muscle Symptoms: Characteristics of Patients and Recommendations by Providers*
|
Khan, Abdullah
|
|
2015
|
9 |
3 |
p. 460-
1 p.
|
artikel
|
| 95 |
Statin-Induced Myopathy in Patients with Familial Hypercholesterolemia
|
Khine, Htet
|
|
2015
|
9 |
3 |
p. 445-447
3 p.
|
artikel
|
| 96 |
Statins and Risk of New Onset Type 2 Diabetes in a Primary Care Setting*
|
Nadolsky, Spencer
|
|
2015
|
9 |
3 |
p. 470-471
2 p.
|
artikel
|
| 97 |
Statin Therapy Impact on Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
|
Alkharabsheh, Saqer Khaled
|
|
2015
|
9 |
3 |
p. 472-473
2 p.
|
artikel
|
| 98 |
Table of Contents
|
|
|
2015
|
9 |
3 |
p. A3-A5
nvt p.
|
artikel
|
| 99 |
Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth
|
McNeal, Catherine J.
|
|
2015
|
9 |
3 |
p. 458-459
2 p.
|
artikel
|
| 100 |
Temporal Trends in Statin Therapy for Familial Hypercholesterolemia in U.S. Youth 2002 – 2012
|
McNeal, Catherine J.
|
|
2015
|
9 |
3 |
p. 457-458
2 p.
|
artikel
|
| 101 |
The association between epicardial fat thickness and coronary artery calcification according to blood pressure status in nonhypertensive individuals: From the CAESAR study
|
Lee, Tae Hoon
|
|
2015
|
9 |
3 |
p. 305-312
8 p.
|
artikel
|
| 102 |
The Diacylglycerol Acyltransferase 1 Inhibitor, Pradigastat, Was Well Tolerated in a 52-Week Clinical Trial in FCS Patients
|
Stroes, Erik S.G.
|
|
2015
|
9 |
3 |
p. 450-
1 p.
|
artikel
|
| 103 |
The extent of familial hypercholesterolemia instruction in US schools and colleges of medicine, pharmacy, and osteopathic medicine
|
Withycombe, Bethany
|
|
2015
|
9 |
3 |
p. 281-288
8 p.
|
artikel
|
| 104 |
The Hepatic Effects of Citrus Bergamot Polyphenol Fraction (BPF) on Patients with Non-alcoholic Fatty Liver Disease and Metabolic Syndrome†
|
Ehrlich, James
|
|
2015
|
9 |
3 |
p. 462-463
2 p.
|
artikel
|
| 105 |
The Impact of Apolipoprotein B Depletion Methods on HDL Subspecies*
|
Shah, Amy S.
|
|
2015
|
9 |
3 |
p. 430-
1 p.
|
artikel
|
| 106 |
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations
|
Di Leo, Enza
|
|
2015
|
9 |
3 |
p. 400-405
6 p.
|
artikel
|
| 107 |
The Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors in Youth with Diabetes
|
Vinson, Amelia
|
|
2015
|
9 |
3 |
p. 417-
1 p.
|
artikel
|
| 108 |
Trends in Treatment Patterns of First Statin and Ezetimibe Use in the United States from 2007-2012
|
Paoli, Carly J.
|
|
2015
|
9 |
3 |
p. 473-
1 p.
|
artikel
|
| 109 |
Triglyceride-Lowering Therapies Reduce Cardiovascular Disease Event Risk in Subjects with Hypertriglyceridemia
|
Maki, Kevin C.
|
|
2015
|
9 |
3 |
p. 431-
1 p.
|
artikel
|
| 110 |
Universal Cholesterol Screening of All 9- to 11-Year-Old Children in Community-Based Ambulatory Pediatric Clinics*
|
Mou, Margaret
|
|
2015
|
9 |
3 |
p. 443-
1 p.
|
artikel
|
| 111 |
Universal vs. Selective Pediatric Lipid Screening in the Diagnosis of Familial Hypercholesterolemia*
|
Hering Peterson, Amy Lynn
|
|
2015
|
9 |
3 |
p. 449-
1 p.
|
artikel
|
| 112 |
Updated cholesterol guidelines and intensity of statin therapy
|
Nguyen, Vincent
|
|
2015
|
9 |
3 |
p. 357-359
3 p.
|
artikel
|
| 113 |
Use of a Blood-Based Age/Sex/Gene Expression Test Was Associated with Prescriptions for Lipid-Lowering Medications and Lifestyle Changes among Symptomatic Patients at Increased Cardiovascular Risk for Obstructive Coronary Artery Disease: Subgroup Analysis
|
Pokrywka, Gregory S.
|
|
2015
|
9 |
3 |
p. 416-417
2 p.
|
artikel
|
| 114 |
Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
|
Thompson, Paul D.
|
|
2015
|
9 |
3 |
p. 295-304
10 p.
|
artikel
|
| 115 |
Utilization of a Clinical Lipid Specialist in a Cardiology Practice in the Era of the 2013 ACC/AHA Guidelines
|
Ciffone, Nicole A.
|
|
2015
|
9 |
3 |
p. 440-441
2 p.
|
artikel
|
Tijdschrift beschrijving